Lumis International

Representing your medical innovation.
Empowering your product development.

Lumis mission is to unlock access to European markets for biopharma and medical device companies through being their trusted regulatory ambassador. 

Founded in 2013 in Berlin, Germany, Lumis began by providing legal representation for non-European small to mid-sized companies conducting clinical trials in Europe. Our subsidiary in the UK underscores our growing international reach and ongoing commitment to supporting clients across borders.

Our trusted reputation has enabled us to expand our services, offering consulting to accelerate the clinical development of innovative drugs and medical devices through full support in clinical trial outsourcing, quality management, and regulatory compliance.

With experience on both sponsor and vendor sides, our team effectively resolves challenges in clinical projects, supported by a broad network of expert partners and consultants.

Lab technicians working on an analysis

What Lumis stands for

Leadership

We take responsibility and proactive initiative, applying these qualities to every project.

Responsibility

We listen, prioritize customer benefits, and tailor our services to meet specific needs.

Trust

We value confidentiality, responsible decisions, transparent communication, and impactful solutions.

Agility

We are flexible, swift, and rapidly adapt to change.

Pragmatism

We emphasize budget and resource awareness, with straightforward, hands-on approaches.

Creativity

We find a solution for every challenge.

Management Board

Heike Schön
Heike Schön

Heike Schön

Shareholder and CEO

Heike Schön, has worked in management positions in clinical research for more than 20 years. Her experience ranges from conducting national and international Phase I clinical trials all the way to registration and post‑marketing activities in various indications. She had positions within the contract research organisations (CROs) and in the biotechnology industry. Her previous positions also included operational and general management. She holds a master’s degree in psychology and a master’s degree in business administration. Since 2002, she has been active in the Association of Clinical Research Professionals (ACRP) where she also served as a member of the Board of Trustees and as its Chair in 2010. Heike is a regular speaker at international conferences and publishes within clinical research and medical device magazines.

Heike Schön

Shareholder and CEO

Myrthe Trompert
Myrthe Trompert

Myrthe Trompert

Shareholder and Member of the Management Board

Myrthe Trompert has worked as a lawyer in the clinical research industry for more than 25 years and as senior legal counsel for countries outside the USA for a global CRO. Since 2010 Myrthe has been the CEO and director legal consultant of Salvius Legal, a company specializing in contract management support for the clinical trial industry. As such, she has gained a thorough knowledge of clinical trial processes and contractual and regulatory requirements for performing clinical trials globally.

Myrthe Trompert

Shareholder and Member of the Management Board

Kurt Miller
Kurt Miller

Prof. Kurt Miller

Shareholder and Member of the Management Board

Since 1993, Kurt Miller has been a Professor of Urology and Department Chair at the Benjamin Franklin Medical Center’s Department of Urology in Berlin, Germany. Until 2019, he has been the Chair of the Department of Urology for the entire Charité University Hospital (Campus Benjamin Franklin, Campus Mitte, and Campus Virchow Klinikum). Between 1998 and 2004, he was the Chair of the Association of Urological Oncology. He was a Member of the Board of the German Urological Association between 2001 and 2003 and a Member of the Board of the German Cancer Society between 2004 and 2008. Kurt Miller has authored more than 300 publications and is the co-editor of the German Textbook of Urology. He serves as a peer reviewer for the German Research Association and for several scientific journals. Kurt Miller has also been the principal investigator of numerous clinical trials in uro-oncology.

Prof. Kurt Miller

Shareholder and Member of the Management Board

Contact us to find out more!

Stella Vu
Contact Us

Your data will be stored to provide you with information on our services and products. You may unsubscribe at any time. Please refer to our privacy policy for more information on how we store your data and how to unsubscribe.